Megan Carr

Megan Carr is Vice President, Investor Relations at Revelstoke Capital Partners, a Denver-based private equity firm focused on healthcare services, healthcare technology, and health & wellness. Revelstoke’s team page says she joined the firm in 2022.

Before Revelstoke, Carr was an Investment Associate at Crest Rock Partners in Denver, where she evaluated investment opportunities across software & technology, IT & business services, and industrial & manufacturing. Prior to Crest Rock, she was an Investment Associate at Monomoy Capital Partners in New York City.

Carr began her career as an Investment Banking Analyst at Credit Suisse. She graduated from the University of Virginia with a B.S. in Commerce, concentrating in Finance, and a double major in English.

• Carr’s current role is investor relations; public sources do not show her as a named deal lead. Her investment context is best understood through Revelstoke’s firm-wide mandate.
• Revelstoke invests in companies at the intersection of healthcare, technology, and consumer, using “strategic capital and a systematic approach to value creation.”
• The firm has a “singular focus” on high-growth, fragmented healthcare markets, including services, technology, and health & wellness.
• Target sectors include behavioral health, dental, home health & hospice, multi-site providers, physician practice management, value-based care, veterinary services, revenue cycle management, specialty EHR/PM, managed IT services, medical aesthetics, and wellness providers.
• Revelstoke’s process is research-driven and thematic: identify themes, map sectors, dedicate resources, leverage networks to engage founders and management teams, and act quickly through diligence.
• The firm prefers control transactions but says it has flexibility across the capital structure and uses a conservative debt approach.